ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646847 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646847; 2) Community: the network communities that were significantly associated with the response to NSC 646847; 3) Molecule: the relationships between components within communities and NSC 646847; 4) MDR: the compounds that were significantly associated with the NSC 646847.

NSC Compound Enrichment Correlation
NSC 77039 Null 0.0422011701988039 0.32801405
NSC 106486 Formycin B 0.0438391811600409 0.15742134
NSC 130279 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) 0.0438391811600409 0.13673132
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.0438391811600409 0.105552
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0438391811600409 0.25247652
NSC 237671 Actinomycin X4357g-methoxime 0.0438391811600409 0.44910393
NSC 305767 2,4-Quinazolinediamine, 6-[(4-chlorophenyl)thio]- 0.0438391811600409 0.35314748
NSC 335753 HELIANGOLIDE 0.0438391811600409 0.27188565
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0438391811600409 0.53229259
NSC 372146 1,3,5-Triazine, 2-(1-methylethenyl)-2,4-diphenoxy- 0.0438391811600409 0.092954474
Total:118  Current:96    [First] [Prev] [Next] [Last]